These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37595204)

  • 1. Impact of Latent M. tuberculosis Infection Treatment on Time to CD4/CD8 Recovery in Acute, Recent, and Chronic HIV Infection.
    Grinsztejn E; Cardoso SW; Velasque L; Hoagland B; Dos Santos DG; Coutinho C; Cruz Silva SDC; Nazer SC; Ferreira ACG; Castilho J; Grinsztejn B; Veloso VG
    J Acquir Immune Defic Syndr; 2023 Dec; 94(4):355-363. PubMed ID: 37595204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute HIV Infection and CD4/CD8 Ratio Normalization After Antiretroviral Therapy Initiation.
    Davy-Mendez T; Napravnik S; Zakharova O; Kuruc J; Gay C; Hicks CB; Mcgee KS; Eron JJ
    J Acquir Immune Defic Syndr; 2018 Dec; 79(4):510-518. PubMed ID: 30142143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of suboptimal CD4
    Handoko R; Colby DJ; Kroon E; Sacdalan C; de Souza M; Pinyakorn S; Prueksakaew P; Munkong C; Ubolyam S; Akapirat S; Chiarella J; Krebs S; Sereti I; Valcour V; Paul R; Michael NL; Phanuphak N; Ananworanich J; Spudich S;
    J Int AIDS Soc; 2020 Sep; 23(9):e25585. PubMed ID: 32949118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased CD4 : CD8 ratio normalization with implementation of current ART management guidelines.
    Zhabokritsky A; Szadkowski L; Cooper C; Loutfy M; Wong A; McClean A; Hogg RS; Walmsley SL;
    J Antimicrob Chemother; 2021 Feb; 76(3):729-737. PubMed ID: 33249444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Framingham risk score based vascular outcomes in acute versus chronic HIV cohorts after 6 years of ART.
    Holroyd KB; Han WM; Apornpong T; Trautmann L; Gatechompol S; Hiransuthikul A; Ubolyam S; Sacdalan C; Sriplienchan S; Kanaprach R; Kerr S; Avihingsanon A; Spudich S; Chan P
    HIV Med; 2024 Jun; 25(6):725-736. PubMed ID: 38383057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robust Reconstitution of Tuberculosis-Specific Polyfunctional CD4+ T-Cell Responses and Rising Systemic Interleukin 6 in Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome.
    Ravimohan S; Tamuhla N; Nfanyana K; Steenhoff AP; Letlhogile R; Frank I; MacGregor RR; Gross R; Weissman D; Bisson GP
    Clin Infect Dis; 2016 Mar; 62(6):795-803. PubMed ID: 26611774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced immunovirological response in women compared to men after antiretroviral therapy initiation during acute and early HIV-1 infection: results from a longitudinal study in the French ANRS Primo cohort.
    Novelli S; Delobel P; Bouchaud O; Avettand-Fenoel V; Fialaire P; Cabié A; Souala F; Raffi F; Catalan P; Weiss L; Meyer L; Goujard C
    J Int AIDS Soc; 2020 Apr; 23(4):e25485. PubMed ID: 32333726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initiation of antiretroviral therapy in HIV-infected tuberculosis patients in rural Kenya: an observational study.
    Stockdale AJ; Nkuranga J; Török ME; Faragher B; Lalloo DG
    Trop Med Int Health; 2013 Jul; 18(7):907-14. PubMed ID: 23590229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of immediate initiation of antiretroviral therapy on risk of severe bacterial infections in HIV-positive people with CD4 cell counts of more than 500 cells per μL: secondary outcome results from a randomised controlled trial.
    O'Connor J; Vjecha MJ; Phillips AN; Angus B; Cooper D; Grinsztejn B; Lopardo G; Das S; Wood R; Wilkin A; Klinker H; Kantipong P; Klingman KL; Jilich D; Herieka E; Denning E; Abubakar I; Gordin F; Lundgren JD;
    Lancet HIV; 2017 Mar; 4(3):e105-e112. PubMed ID: 28063815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active tuberculosis is associated with worse clinical outcomes in HIV-infected African patients on antiretroviral therapy.
    Siika AM; Yiannoutsos CT; Wools-Kaloustian KK; Musick BS; Mwangi AW; Diero LO; Kimaiyo SN; Tierney WM; Carter JE
    PLoS One; 2013; 8(1):e53022. PubMed ID: 23301015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low levels of peripheral CD161++CD8+ mucosal associated invariant T (MAIT) cells are found in HIV and HIV/TB co-infection.
    Wong EB; Akilimali NA; Govender P; Sullivan ZA; Cosgrove C; Pillay M; Lewinsohn DM; Bishai WR; Walker BD; Ndung'u T; Klenerman P; Kasprowicz VO
    PLoS One; 2013; 8(12):e83474. PubMed ID: 24391773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of CD4/CD8 ratio on the incidence of tuberculosis in HIV-infected patients on antiretroviral therapy followed up for more than a decade.
    Wolday D; Kebede Y; Legesse D; Siraj DS; McBride JA; Kirsch MJ; Striker R
    PLoS One; 2020; 15(5):e0233049. PubMed ID: 32442166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brief Report: Enhanced Normalization of CD4/CD8 Ratio With Earlier Antiretroviral Therapy at Primary HIV Infection.
    Thornhill J; Inshaw J; Kaleebu P; Cooper D; Ramjee G; Schechter M; Tambussi G; Fox J; Samuel M; Miro JM; Weber J; Porter K; Fidler S
    J Acquir Immune Defic Syndr; 2016 Sep; 73(1):69-73. PubMed ID: 27070122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of antiretroviral and tuberculosis therapies on CD4
    Chiacchio T; Petruccioli E; Vanini V; Cuzzi G; La Manna MP; Orlando V; Pinnetti C; Sampaolesi A; Antinori A; Caccamo N; Goletti D
    Immunol Lett; 2018 Jun; 198():33-43. PubMed ID: 29635002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal analysis of immune reconstitution and metabolic changes in women living with HIV: A real-world observational study.
    Wang X; Xiao J; Zhang L; Liu Y; Chen N; Deng M; Song C; Liu T; Zhang Y; Zhao H
    Chin Med J (Engl); 2023 Sep; 136(18):2168-2177. PubMed ID: 37580056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of Tuberculosis Among HIV-Positive Individuals Initiating Antiretroviral Treatment at Higher CD4 Counts in the HPTN 071 (PopART) Trial in South Africa.
    Bock P; Jennings K; Vermaak R; Cox H; Meintjes G; Fatti G; Kruger J; De Azevedo V; Maschilla L; Louis F; Gunst C; Grobbelaar N; Dunbar R; Limbada M; Floyd S; Grimwood A; Ayles H; Hayes R; Fidler S; Beyers N
    J Acquir Immune Defic Syndr; 2018 Jan; 77(1):93-101. PubMed ID: 29016524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4
    Vivancos-Gallego MJ; Okhai H; Perez-Elías MJ; Gomez-Ayerbe C; Moreno-Zamora A; Casado JL; Quereda C; Sanz JM; Sanchez-Conde M; Serrano-Villar S; Del Campo S; Dronda F; Galan JC; Sabin CA; Moreno S
    Antivir Ther; 2020; 25(2):91-100. PubMed ID: 32338638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience, 1995-2001.
    Miranda A; Morgan M; Jamal L; Laserson K; Barreira D; Silva G; Santos J; Wells C; Paine P; Garrett D
    PLoS One; 2007 Sep; 2(9):e826. PubMed ID: 17786198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demographic and clinical factors correlated with clinical outcomes among people with HIV treated by antiretroviral therapy: a retrospective cohort study.
    Li Y; Liu H; Zhang S; Zhang Y; Wang H; Zhang H; Li X
    BMC Infect Dis; 2024 May; 24(1):514. PubMed ID: 38778273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T lymphocyte subpopulations and intestinal helminthes profile among tuberculosis patients co-infected with HIV before and after anti tubercular treatment at University of Gondar Hospital, Northwest Ethiopia.
    Wondmagegn T; Damtie D; Genetu M; Biadgo B; Lemma M; Negash M
    BMC Infect Dis; 2020 Feb; 20(1):109. PubMed ID: 32033581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.